Tutogen Medical (TTG) Reports Q4 Earnings
Tutogen Medical Inc. (NYSE: TTG) reported a Q4 loss of $0.02, including items, versus the ex-items analyst estimate of $0.04. Revenues for the quarter were $15.2 million, versus the consensus of $14.27 million.
Tutogen Medical, Inc., together with its subsidiaries, engages in the design, development, process, manufacture, and marketing of surgical products primarily in the United States.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
